Cargando…
In vitro culture with gemcitabine augments death receptor and NKG2D ligand expression on tumour cells
Much effort has been made to try to understand the relationship between chemotherapeutic treatment of cancer and the immune system. Whereas much of that focus has been on the direct effect of chemotherapy drugs on immune cells and the release of antigens and danger signals by malignant cells killed...
Autores principales: | Gravett, Andrew M., Dalgleish, Angus G., Copier, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367314/ https://www.ncbi.nlm.nih.gov/pubmed/30733494 http://dx.doi.org/10.1038/s41598-018-38190-2 |
Ejemplares similares
-
Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells
por: Gravett, A. M., et al.
Publicado: (2018) -
The efficacy of chemotherapeutic drug combinations may be predicted by concordance of gene response to the single agents
por: Gravett, Andrew M., et al.
Publicado: (2020) -
The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer
por: Tan, Ge, et al.
Publicado: (2023) -
Xanthine oxidoreductase is required for genotoxic stress-induced NKG2D ligand expression and gemcitabine-mediated antitumor activity
por: Xu, Xiulong, et al.
Publicado: (2016) -
Smoking induces expression of ligands of the immune receptor NKG2D
por: Ospelt, Caroline, et al.
Publicado: (2012)